Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Efficacy of 25 mg etanercept once weekly in rheumatoid arthritis

  • At: 2009 FIP Congress in Istanbul (Turkey)
  • Type: Poster
  • By: IWAKI-EGAWA, Sachiko (Hokkaido Pharmaceutical University, Otaru, Japan)
  • Co-author(s): Hiura, Kazuya (Obihiro Kosei General Hospital, OBIHIRO, Japan)
    Hayashi, Chikage (Hokkaido Pharmaceutical University, OTARU, Japan)
    Houjou, Saneyuki (Engaru Kosei General Hospital, ENGARU, Japan)
    Takeda, Tsuyoshi (Obihiro Kosei General Hospital, OBIHIRO, Japan)
    Arai, Kiminori (Obihiro Kosei General Hospital, OBIHIRO, Japan)
    Watanabe, Yasuhiro (Hokkaido Pharmaceutical University, OTARU, Japan)
  • Abstract:

    Background. Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation involving large and small joints, extracellular matrix degradation, destruction of joint cartilage, and loss of function. Tumor necrosis factor- α (TNF-α) plays a major role in RA by amplifying inflammation in multiple pathways that lead to joint..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses